Misoprostol Now Included on Nigeria’s Essential Drug List
April 28, 2011 | Grantee News | Population & Reproductive Health

Nigeria's Federal Ministry of Health has approved the inclusion of misoprostol on the Essential Drug List (EDL). Misoprostol is used for the prevention and treatment of postpartum hemorrhage, a leading cause of maternal mortality. Its inclusion on the EDL, which gives the drug the status of national priority, follows a MacArthur-supported research report on community-based use of the drug conducted by Dr. Clara Ejembi at Ahmadu Bello University in Zaria.

Stay Informed
Sign up for periodic news updates and event invitations.
Connect with us on social media or view all of our social media content in one place.

The privacy of your data is important to us. We've updated our privacy policies in response to General Data Protection Regulation.